Since 1992, Omnicell has been creating innovative solutions to improve patient care, anywhere it is delivered. The Company is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire healthcare continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities, to the patient’s home. A lot of customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry. The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions.
Type
Public
HQ
Mountain View, US
Founded
1992
Size (employees)
2,444 (est)
Omnicell was founded in 1992 and is headquartered in Mountain View, US
Report incorrect company information

Key People/Management at Omnicell

Randall Lipps

Randall Lipps

Chairman, President, Chief Executive Officer, and Founder
Dan Johnston

Dan Johnston

Executive Vice President and Chief Legal and Administrative Officer
Peter Kuipers

Peter Kuipers

Executive Vice President and Chief Financial Officer
Nhat Ngo

Nhat Ngo

Executive Vice President, Marketing, Strategy & Business Development
Scott Seidelmann

Scott Seidelmann

Chief Commercial Officer
Rob Seim

Rob Seim

President, Global Automation and Medication Adherence
Show more

Omnicell Office Locations

Omnicell has offices in Warrendale, Cranberry Township, Waukegan, Saint Petersburg and in 2 other locations
Mountain View, US (HQ)
590 E Middlefield Rd
Cranberry Township, US
500 Cranberry Woods Dr
Milpitas, US
725 Sycamore Dr
Saint Petersburg, US
2003 Gandy Blvd N
Warrendale, US
400 51 Pennwood Pl
Waukegan, US
Burwood Drive
Show all (6)
Report incorrect company information

Omnicell Financials and Metrics

Omnicell Financials

Omnicell's revenue was reported to be $716.17 m in FY, 2017
USD

Revenue (Q1, 2018)

182.6 m

Gross profit (Q1, 2018)

82.5 m

Gross profit margin (Q1, 2018), %

45.2%

Net income (Q1, 2018)

2.7 m

EBIT (Q1, 2018)

633 k

Market capitalization (25-May-2018)

1.8 b

Closing share price (25-May-2018)

45.9

Cash (31-Mar-2018)

43.8 m

EV

1.9 b
Omnicell's current market capitalization is $1.8 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

380.6 m440.9 m484.6 m692.6 m716.2 m

Revenue growth, %

16%10%43%

Cost of goods sold

177.2 m207 m236.6 m378.8 m394.1 m

Gross profit

203.4 m233.9 m247.9 m313.8 m322.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

94 m101.8 m105.1 m112.5 m116.2 m112.8 m125.2 m171 m172.9 m176.7 m150.6 m180.9 m182.6 m

Cost of goods sold

42 m47.3 m49 m53 m54.5 m55.3 m61.5 m91.1 m94.9 m95.2 m86.4 m102.9 m100.2 m

Gross profit

52 m54.5 m56 m59.5 m61.7 m57.5 m63.7 m79.9 m78 m81.5 m64.2 m78 m82.5 m

Gross profit Margin, %

55%54%53%53%53%51%51%47%45%46%43%43%45%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

104.5 m125.9 m82.2 m54.5 m32.4 m

Accounts Receivable

598 k

Inventories

31.5 m46.6 m69.3 m96.1 m

Current Assets

233.8 m283.4 m264.1 m315.4 m367.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

116.2 m107.6 m126.4 m104.2 m139.6 m88 m57.8 m53.5 m41 m47.3 m46.3 m26.9 m43.8 m

Inventories

30.7 m31 m31.5 m31.8 m33.2 m46 m49.5 m71.9 m73.7 m74.1 m76.2 m81.5 m101.9 m

Current Assets

247.9 m250.8 m275.9 m268.4 m296.3 m285.3 m259.9 m310.3 m311.9 m337.1 m294.4 m296 m372.2 m

PP&E

33.5 m35.2 m37.3 m37.7 m34.4 m34.8 m34 m42.2 m40.5 m41 m41 m40.7 m48.3 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

24 m30.5 m30.8 m603 k20.6 m

Depreciation and Amortization

18.4 m20.3 m25.6 m58.4 m51.5 m

Inventories

(5.4 m)1.4 m(10 m)(3.4 m)(26.8 m)

Accounts Payable

(1.8 m)1.6 m(2.8 m)(5 m)19.7 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

7.8 m6.2 m7.8 m7.3 m6.3 m8.8 m8 m(378 k)(1.2 m)2 m(10.8 m)2.7 m

Depreciation and Amortization

12.3 m

Inventories

31.5 m31.8 m49.5 m71.9 m73.7 m74.1 m76.2 m(6.9 m)

Accounts Payable

19 m23.2 m21.8 m26.1 m24.7 m32.1 m37.4 m36.7 m38.5 m(9.4 m)
USDY, 2018

EV/EBIT

3 k x

EV/CFO

102.3 x

Financial Leverage

1.8 x
Show all financial metrics
Report incorrect company information

Omnicell News and Updates

North America Medical Carts Market to exhibit a CAGR of nearly 11.2% during the forecast period 2017-2027

Future Market Insights has announced the addition of the “Medical Carts Market: North America Industry Analysis and Opportunity Assessment 2017-2027" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

Pharmacy IT specialist Positive Solutions partners with Cambrian Alliance Group

Integrated pharmacy systems now available to Cambrian Alliance Group members at discounted rates Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information